Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency

Journal of Immunological Methods

Volumn 362, Issue 1-2, 2010, Pages 1-9

  Marsh, Rebecca A ^a   Bleesing, Jack J ^a   Filipovich, Alexandra H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

BIRC4; Hemophagocytic lymphohistiocytosis; SAP; SH2D1A; X linked lymphoproliferative disease; XIAP

Indexed keywords

SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DYSGAMMAGLOBULINEMIA; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE MUTATION; GENE SEQUENCE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOSTIMULATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVIEW; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN DEFICIENCY; X LINKED INHIBITOR OF APOPTOSIS PROTEIN DEFICIENCY; X LINKED LYMPHOPROLIFERATIVE DISEASE;

FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC DISEASES, X-LINKED; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MUTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

HUMAN HERPESVIRUS 4;

EID: 77958509989     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.08.010     Document Type: Review

References (44)

1. Aghamohammadi A., Kanegane H., Moein M., Farhoudi A., Pourpak Z., Movahedi M., Gharagozlou M., Zargar A.A., Miyawaki T. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int. J. Hematol. 2003, 78:45.
2. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., Wakeland E.K., Germain R.N., Schwartzberg P.L. Optimal germinal center responses require a multistage T Cell:B Cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253.
3. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., Shi Y. Structural basis of caspase-7 inhibition by XIAP. Cell 2001, 104:769.
4. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., Bolino A., Seri M., Lanyi A., Davis J.R., Webster D., Harris A., Lenoir G., de St Basile G., Jones A., Behloradsky B.H., Achatz H., Murken J., Fassler R., Sumegi J., Romeo G., Vaudin M., Ross M.T., Meindl A., Bentley D.R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998, 20:129.
5. Donnenberg A.D., Donnenberg V.S. Rare-event analysis in flow cytometry. Clin. Lab. Med. 2007, 27:627. viii.
6. Duckett C.S., Nava V.E., Gedrich R.W., Clem R.J., Van Dongen J.L., Gilfillan M.C., Shiels H., Hardwick J.M., Thompson C.B. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 1996, 15:2685.
7. Dutz J.P., Benoit L., Wang X., Demetrick D.J., Junker A., de Sa D., Tan R. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 2001, 97:95.
8. Galban S., Duckett C.S. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010, 17:54.
9. Godfrey D.I., Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004, 114:1379.
10. Harrington D.S., Weisenburger D.D., Purtilo D.T. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 1987, 59:1419.
11. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., Wu H. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 2001, 104:781.
12. Kanegane H., Ito Y., Ohshima K., Shichijo T., Tomimasu K., Nomura K., Futatani T., Sumazaki R., Miyawaki T. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis. Am. J. Hematol. 2005, 78:130.
13. Kaur S., Wang F., Venkatraman M., Arsura M. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J. Biol. Chem. 2005, 280:38599.
14. Krieg A., Correa R.G., Garrison J.B., Le Negrate G., Welsh K., Huang Z., Knoefel W.T., Reed J.C. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl Acad. Sci. USA 2009, 106:14524.
15. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999, 17:221.
16. Lewis J., Burstein E., Reffey S.B., Bratton S.B., Roberts A.B., Duckett C.S. Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J. Biol. Chem. 2004, 279:9023.
17. Lu M., Lin S.C., Huang Y., Kang Y.J., Rich R., Lo Y.C., Myszka D., Han J., Wu H. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell 2007, 26:689.
18. Ma C.S., Nichols K.E., Tangye S.G. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 2007, 25:337.
19. Marsh R.A., Villanueva J., Kim M.O., Zhang K., Marmer D., Risma K.A., Jordan M.B., Bleesing J.J., Filipovich A.H. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin. Immunol. 2009, 132:116.
20. Marsh R.A., Villanueva J., Zhang K., Snow A.L., Su H.C., Madden L., Mody R., Kitchen B., Marmer D., Jordan M.B., Risma K.A., Filipovich A.H., Bleesing J.J. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytom. B Clin. Cytom. 2009, 76:334.
21. Marsh R.A., Madden L., Kitchen B.J., Mody R., McClimon B., Jordan M.B., Bleesing J.J., Zhang K., Filipovich A.H. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 2010, 116:1079.
22. Nagy N., Matskova L., Kis L.L., Hellman U., Klein G., Klein E. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. Proc. Natl Acad. Sci. USA 2009, 106:11966.
23. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 1998, 95:13765.
24. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., Tangye S.G., Schwartzberg P.L., Koretzky G.A., Stein P.L. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 2005, 11:340.
25. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 2005, 201:695.
26. Purtilo D.T., Grierson H.L. Methods of detection of new families with X-linked lymphoproliferative disease. Cancer Genet. Cytogenet. 1991, 51:143.
27. Purtilo D.T., Cassel C.K., Yang J.P., Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975, 1:935.
28. Qi H., Cannons J.L., Klauschen F., Schwartzberg P.L., Germain R.N. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 2008, 455:764.
29. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., de Saint Basile G., Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110.
30. Roederer M. How many events is enough? Are you positive?. Cytom. A 2008, 73:384.
31. Sanna M.G., Duckett C.S., Richter B.W., Thompson C.B., Ulevitch R.J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl Acad. Sci. USA 1998, 95:6015.
32. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998, 395:462.
33. Scott F.L., Denault J.B., Riedl S.J., Shin H., Renatus M., Salvesen G.S. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 2005, 24:645.
34. Seemayer T.A., Gross T.G., Egeler R.M., Pirruccello S.J., Davis J.R., Kelly C.M., Okano M., Lanyi A., Sumegi J. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 1995, 38:471.
35. Shinozaki K., Kanegane H., Matsukura H., Sumazaki R., Tsuchida M., Makita M., Kimoto Y., Kanai R., Tsumura K., Kondoh T., Moriuchi H., Miyawaki T. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Int. Immunol. 2002, 14:1215.
36. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., Alnemri E.S., Fairman R., Shi Y. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 2003, 11:519.
37. Snow A.L., Marsh R.A., Krummey S.M., Roehrs P., Young L.R., Zhang K., van Hoff J., Dhar D., Nichols K.E., Filipovich A.H., Su H.C., Bleesing J.J., Lenardo M.J. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 2009, 119:2976.
38. Snow A.L., Pandiyan P., Zheng L., Krummey S.M., Lenardo M.J. The power and the promise of restimulation-induced cell death in human immune diseases. Immunol. Rev. 2010, 236:68.
39. Soresina A., Lougaris V., Giliani S., Cardinale F., Armenio L., Cattalini M., Notarangelo L.D., Plebani A. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. Eur. J. Pediatr. 2002, 161:656.
40. Tabata Y., Villanueva J., Lee S.M., Zhang K., Kanegane H., Miyawaki T., Sumegi J., Filipovich A.H. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 2005, 105:3066.
41. Talaat K.R., Rothman J.A., Cohen J.I., Santi M., Choi J.K., Guzman M., Zimmerman R., Nallasamy S., Brucker A., Quezado M., Pittaluga S., Patronas N.J., Klion A.D., Nichols K.E. Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. Pediatr. Blood Cancer 2009, 53:1120.
42. Yamaguchi K., Nagai S., Ninomiya-Tsuji J., Nishita M., Tamai K., Irie K., Ueno N., Nishida E., Shibuya H., Matsumoto K. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 1999, 18:179.
43. Yang Y., Fang S., Jensen J.P., Weissman A.M., Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000, 288:874.
44. Zhao M., Kanegane H., Ouchi K., Imamura T., Latour S., Miyawaki T. A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica 2010, 95:688.